Optimizing Treatment and Management of HIV/AIDS in Persons of

Download Report

Transcript Optimizing Treatment and Management of HIV/AIDS in Persons of

HIV, Tuberculosis and Criminal Justice
The Perfect Storm
Frederick L. Altice, M.D., M.A.
Professor of Medicine and Public Health
Yale University (USA)
University of Malaya (Malaysia)
1
Prisons and Tuberculosis
● Nearly 10 million people imprisoned (4-6X more
transition through annually)
● Highly dynamic and unpredictable movement
- Police detention
- Compulsory drug detention centers
- Jails (remand)
- Prisons
● TB & HIV significantly concentrated in prisons
2
Overcrowding & poor nutrition
Increased “selection” of high risk persons entering
prisons (PWIDs, homeless, PWLHA)
Creating the Perfect Storm
Environment
Host
Crowding
Poor ventilation
Prevalence &
Incidence of
active & LTBI
MDR strains (%)
PWIDs
Homeless
Malnourished
Other Prison
Settings
3
Organism
TB
Dynamics
Communities
Tuberculosis in Prisons
● TB outbreaks reported in many prisons,
especially MDR-TB in FSU (but also in high
income countries with low TB prevalence).
● Prison-related TB transmission is more likely to
be drug-resistant or associated with HIV coinfection.
● A higher proportion of TB patients in prisons
have MDR-strains than is the case in patients
outside prison (incomplete treatment due to
release and poor treatment standards).
WHO Europe, Prison health – HIV, drugs and tuberculosis, 2009
4
HIV Segregation and TB Outbreaks
● PLWHA are at increased risk for acquisition and
progression to active TB
● Entry into a HIV segregation unit by a single
active TB case results in a high probability of TB
transmission and disease progression
● Crowding and poor ventilation results in
increased transmissibility
● Inadequate screening, poor isolation
procedures, substandard treatment and default
on treatment post-release results in
development of drug-resistant strains
5
Prisons, TB and HIV
● 50-80% of prison-related mortality related to TB
(especially TB/HIV coinfection)
● The War on Drug Users has resulted in
incredibly high prevalence of PWIDs / drug
dependent persons in prisons (up to 50%) in
some settings (Eastern Europe and SE Asia)
● Prisons are “high risk” work environments for
staff, especially related to TB (some staff HIV+)
● Nearly all prisoners return to the community and
amplify TB risk to family and the general public
6
Case Study: Malaysia
● Middle income country: 102 TB cases/100,000
● Prisoners: ~38,000
● Mandatory HIV testing with segregation: 5-6%
● Nearly all HIV+ prisoners meet criteria for opioid
dependence (methadone available)
● No systematic TB screening procedures
● See Poster WEPE467 (Al-Darraji et al)
7
-
HIGH cross-sectional active TB prevalence using
Gene Xpert plus culture for TB case finding
-
Symptom-based screening fared poorly
LTBI and the Prison Risk Environment
100%
87.6%
90%
88.8%
81.0%
80%
70%
60%
52.1%
50%
40%
36.0%
30%
TST+ independently
correlated with
previous incarcerations
20%
10%
8
Community
SE Asia
Healthcare
Workers, MY
Open Prison,
Kelantan, MY
Closed Prison Prison Officers
Selangor, MY Selangor, MY
Dye, JAMA,
1999
Rafiza, BMC Infect
Dis, 2011
Margolis, IJTBLD,
2013
Al-Darraji, BMC
Pub Health, 2013
Al-Darraji, Unpub
Data, 2013
Prevalence of LTBI Among Prisoners in
Kelantan, Malaysia
*
*
*p=0.005
Margolis, IJTBLD, In Press
9
Independent Correlates of TST+
and TB Symptoms (N=259)
● TST reactivity
-
Previously incarcerated
AOR (95% CI)
4.61 (1.76-12.10)
● TB symptoms
-
Age
1.07 (1.01-1.13)
BMI
0.82 (0.70-0.96)
Negative TST ( CD4)
3.46 (1.20-9.97)
Margolis, IJTBLD, In Press
10
Deterministic Compartmental TB Model
Reinfection
Susceptible
S
Latent TB
(Recent) L1
Rapid
Progression
Reactivation
Active TB
A
Reinfection
Treatment /
Self-Cure
Relapse
11
Latent TB
(Remote) L2
Immune
Stabilization
TB Recovery
R
Key Assumptions
● Passive diagnosis is baseline simulation to
compare interventions against
● Systematic reviews used to generate estimates
of intervention sensitivity among HIV-negatives
and HIV-positives (CD4 stratification)
● All new screening interventions are annual,
independent of HIV status
● HIV prevalence in prison ~5-6% (Malaysia)
● Not any significant MDR-TB strains
● Impact of 4 Screening Interventions
Basu S et al, In Preparation
12
Reduction in TB Prevalence Using
Various Screening Interventions
40%
% change in prevalence
35%
30%
25%
20%
15%
10%
5%
16%
35%
28%
37%
Symptom
screening
CXR
Sputum AFB
Xpert
0%
13
Basu S et al, In Preparation
Reduction in TB Incidence Using
Various Screening Interventions
% change in incidence
60%
50%
40%
30%
20%
10%
39%
31%
Symptom
screening
CXR
49%
52%
0%
14
Sputum AFB
Xpert
Basu S et al, In Preparation
Reduction in TB Mortality Using
Various Screening Interventions
75%
% change in mortality
65%
55%
45%
35%
25%
15%
5%
-5%
15
47%
52%
61%
67%
Symptom
screening
CXR
Sputum AFB
Xpert
Basu S et al, In Preparation
Potential Intervention Approaches
to Prevent TB Transmission
Improve Screening for
TB Methods
●
●
●
●
Symptom-based screening
CXR screening
Sputum AFB screening
Gene Xpert +/- culture
Alter Prison Environment
●
●
●
●
16
Increase Ventilation
UV light
Specialty TB Prisons
Stop HIV segregation
Decrease Host Susceptibility
to TB Infection
● Isoniazid Preventive
Therapy (HIV+s? TST+s?)
● Routine HIV Testing and
Provision of ART
Structural Changes
● Alternatives to
incarceration for PWIDs
● OST for PWIDs
Simultaneous Use of Different Classes
of TB Control Strategies
Routine HIV
Testing,
Linkage to
ART
OST for
Opioid
Dependent
Patients
Alternatives
to
Incarceration
17
Isoniazid
Preventive
Therapy
Combination
TB Control
Strategies
Routine TB
Screening
Isoniazid Preventive Therapy in
Correctional Facilities
● 18 studies reviewed, including prisons (N=7) and
jails (N=11)
● None included low or middle income countries
(USA, Spain, Singapore)
● Completion rates markedly lower in jails than in
prisons
● Requires ruling out active TB
● Not examined in high prevalence setting of PWIDs
where HCV prevalence high (hepatoxicity)
Al-Darraji, IJTBLD, 2012
18
Summary
● Good prisoner health IS good public health!
● Approaches to increase detection and treatment
of TB in communities should be applied to
prisons where the epidemic is concentrated
● Alternatives to reduce incarceration should be
considered paramount to optimal TB control
● Will need to examine the impact of combination
clinical TB prevention in real-world settings and
apply them to High, Middle and Low Income
settings
19
Acknowledgements
● University of Malaya
-
Haider Al-Darraji *
Adeeba Kamarulzaman
● Yale University
-
Jeffrey Wickersham
● Sanjay Basu –
Stanford
● Fabienne Hariga –
UNODC
20
● Malaysia Prisons
Department
● Sergey Dvoryak –
UIPHP
● Lucas Weissing
● Study participants!